ACS Updates Prostate Cancer Screening Guidance
The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer outweigh the harms, recommending biennial screening from ages 50–69 for average-risk men; annual screening from ages 45–69 for Black men and non-Black men with a strong family history; biennial screening from ages 45–69 for non-Black […]